49 related articles for article (PubMed ID: 25434449)
1. A case of concurrent follicular lymphoma and lung cancer requiring differentiation from lymph node metastasis.
Takahara Y; Nagae S; Yamagata A; Iijima Y; Shioya A; Yamada S; Uramoto H
Thorac Cancer; 2024 Apr; 15(12):1034-1037. PubMed ID: 38480470
[TBL] [Abstract][Full Text] [Related]
2. [Primary Pulmonary Diffuse Large B-cell Lymphoma Mimics Advanced Lung Cancer:Report of a Case].
Ito D; Suzuki H; Shomura S
Kyobu Geka; 2024 May; 77(5):389-393. PubMed ID: 38720609
[TBL] [Abstract][Full Text] [Related]
3. Bilateral synchronous double primary lung cancer: A case report.
Li J; Yin B; Liu Y; Huang H
Clin Case Rep; 2024 Apr; 12(4):e8635. PubMed ID: 38566979
[TBL] [Abstract][Full Text] [Related]
4. Non-Mucinous Lepidic Predominant Adenocarcinoma Presenting with Extensive Aerogenous Spread.
Takanashi Y; Tajima S; Tsukui M; Shinmura K; Hayakawa T; Takahashi T; Neyatani H; Funai K
Rare Tumors; 2016 Nov; 8(4):6580. PubMed ID: 28058100
[TBL] [Abstract][Full Text] [Related]
5. Haemodialysed patient with lung cancer in the COVID-19 era: a clinical challenge.
Carvalho TP; Trinca F; Cardoso T; Dinis R
BMJ Case Rep; 2021 Jul; 14(7):. PubMed ID: 34326113
[TBL] [Abstract][Full Text] [Related]
6. Synchronous Multiple Primary Cancers of the Lung: The Rare Association of Non-Small Cell Carcinoma With a Carcinoid Tumor.
Parsi M; Vivacqua RJ
Cureus; 2020 Aug; 12(8):e9888. PubMed ID: 32968554
[TBL] [Abstract][Full Text] [Related]
7. Destroyed lung due to sustained inflammation after chemoradiotherapy followed by durvalumab.
Taima K; Tanaka H; Itoga M; Ishioka Y; Kurose A; Tasaka S
Respirol Case Rep; 2020 Jul; 8(5):e00580. PubMed ID: 32399215
[TBL] [Abstract][Full Text] [Related]
8. A randomized phase II study of the telomerase inhibitor imetelstat as maintenance therapy for advanced non-small-cell lung cancer.
Chiappori AA; Kolevska T; Spigel DR; Hager S; Rarick M; Gadgeel S; Blais N; Von Pawel J; Hart L; Reck M; Bassett E; Burington B; Schiller JH
Ann Oncol; 2015 Feb; 26(2):354-62. PubMed ID: 25467017
[TBL] [Abstract][Full Text] [Related]
9. Italian multicenter phase III randomized study of cisplatin-etoposide with or without bevacizumab as first-line treatment in extensive stage small cell lung cancer: treatment rationale and protocol design of the GOIRC-AIFA FARM6PMFJM trial.
Tiseo M; Boni L; Ambrosio F; Camerini A; Vitale MG; Baldini E; Cinieri S; Zanelli F; Defraia E; Passalacqua R; Crino L; Dazzi C; Tibaldi C; Turolla GM; D'Alessandro V; Zilembo N; Riccardi F; Ardizzoni A;
Clin Lung Cancer; 2015 Jan; 16(1):67-70. PubMed ID: 25450879
[TBL] [Abstract][Full Text] [Related]
10. Exploratory Subset Analysis of African Americans From the PointBreak Study: Pemetrexed-Carboplatin-Bevacizumab Followed by Maintenance Pemetrexed-Bevacizumab Versus Paclitaxel-Carboplatin-Bevacizumab Followed by Maintenance Bevacizumab in Patients With Stage IIIB/IV Nonsquamous Non-Small-Cell Lung Cancer.
Reynolds CH; Patel JD; Garon EB; Olsen MR; Bonomi P; Govindan R; Pennella EJ; Liu J; Guba SC; Li S; Spigel DR; Hermann RC; Socinski MA; Obasaju CK
Clin Lung Cancer; 2015 May; 16(3):200-8. PubMed ID: 25516338
[TBL] [Abstract][Full Text] [Related]
11. Anti-vascular endothelial growth factor therapy in breast cancer.
Kristensen TB; Knutsson ML; Wehland M; Laursen BE; Grimm D; Warnke E; Magnusson NE
Int J Mol Sci; 2014 Dec; 15(12):23024-41. PubMed ID: 25514409
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathological factors affecting progression-free survival of patients with previously treated advanced non-small cell lung cancer after S-1 therapy with or without bevacizumab.
Masago K; Fujita S; Hata A; Kaji R; Ohtsuka K; Okuda C; Takeshita J; Katakami N
Anticancer Res; 2014 Dec; 34(12):7467-72. PubMed ID: 25503189
[TBL] [Abstract][Full Text] [Related]
13. Do elderly patients with non-small cell lung cancer get the best out of recent advances in first-line treatment? A comparative study in two tertiary cancer centers in Greece.
Bakogeorgos M; Mountzios G; Bournakis E; Economopoulou P; Kotsantis G; Fytrakis N; Kouvatseas G; Dimopoulos MA; Kentepozidis N
J Geriatr Oncol; 2015 Mar; 6(2):111-8. PubMed ID: 25482021
[TBL] [Abstract][Full Text] [Related]
14. A systematic review of the cost-effectiveness of targeted therapies for metastatic non-small cell lung cancer (NSCLC).
Lange A; Prenzler A; Frank M; Golpon H; Welte T; von der Schulenburg JM
BMC Pulm Med; 2014 Dec; 14():192. PubMed ID: 25471553
[TBL] [Abstract][Full Text] [Related]
15. [A case of cStage III B non-squamous non-small-cell lung cancer completely resected after downstaging with chemotherapy].
Miyahara E; Itagaki T; Kuwahara M; Kameda A; Sentan K
Gan To Kagaku Ryoho; 2014 Nov; 41(11):1429-32. PubMed ID: 25434449
[TBL] [Abstract][Full Text] [Related]
16. [Multimodal treatment of non small cell lung cancer].
Stoelben E; Digel W; Henke M; Passlick B
Zentralbl Chir; 2006 Apr; 131(2):110-4. PubMed ID: 16612776
[TBL] [Abstract][Full Text] [Related]
17. [A case of complete resection of non-squamous non-small-cell lung cancer after induction chemotherapy using carboplatin, paclitaxel, and bevacizumab].
Kawaharada Y; Imai K; Minamiya Y; Saito H; Konno H; Fujishima S; Ogawa J
Gan To Kagaku Ryoho; 2012 Oct; 39(10):1533-7. PubMed ID: 23064066
[TBL] [Abstract][Full Text] [Related]
18. A case of G-CSF-producing invasive apical cancer resected following preoperative adjuvant therapy.
Takagi Y; Nakamura H; Miwa K; Adachi Y; Fujioka S; Haruki T; Taniguchi Y
Thorac Cardiovasc Surg; 2010 Aug; 58(5):304-6. PubMed ID: 20680910
[TBL] [Abstract][Full Text] [Related]
19. [A case of endobronchial squamous cell lung cancer successfully treated with weekly chemotherapy of carboplatin and paclitaxel].
Kambayashi T; Ri M; Yanagihara K; Miyahara R; Bando T; Hasegawa S; Inui K; Wada H
Gan To Kagaku Ryoho; 2003 Jun; 30(6):841-4. PubMed ID: 12852353
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
